These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 17327908)
21. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells. Stordal BK; Davey MW; Davey RA Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310 [TBL] [Abstract][Full Text] [Related]
22. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis. He Y; Liu XD; Chen ZY; Zhu J; Xiong Y; Li K; Dong JH; Li X Clin Cancer Res; 2007 Jun; 13(11):3115-24. PubMed ID: 17545513 [TBL] [Abstract][Full Text] [Related]
23. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87). Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401 [TBL] [Abstract][Full Text] [Related]
24. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator. Mahanivong C; Yu J; Huang S Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542 [TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer. Grøndahl-Hansen J; Peters HA; van Putten WL; Look MP; Pappot H; Rønne E; Dano K; Klijn JG; Brünner N; Foekens JA Clin Cancer Res; 1995 Oct; 1(10):1079-87. PubMed ID: 9815897 [TBL] [Abstract][Full Text] [Related]
26. Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cells. Gorantla B; Asuthkar S; Rao JS; Patel J; Gondi CS Mol Cancer Res; 2011 Apr; 9(4):377-89. PubMed ID: 21389187 [TBL] [Abstract][Full Text] [Related]
27. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer. Kohmo S; Kijima T; Otani Y; Mori M; Minami T; Takahashi R; Nagatomo I; Takeda Y; Kida H; Goya S; Yoshida M; Kumagai T; Tachibana I; Yokota S; Kawase I Cancer Res; 2010 Oct; 70(20):8025-35. PubMed ID: 20940407 [TBL] [Abstract][Full Text] [Related]
28. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Plesner T; Behrendt N; Ploug M Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652 [TBL] [Abstract][Full Text] [Related]
29. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling. Xue A; Xue M; Jackson C; Smith RC Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314 [TBL] [Abstract][Full Text] [Related]
30. Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428. Xing RH; Mazar A; Henkin J; Rabbani SA Cancer Res; 1997 Aug; 57(16):3585-93. PubMed ID: 9270032 [TBL] [Abstract][Full Text] [Related]
31. Localization and significance of urokinase plasminogen activator and its receptor in placental tissue from intrauterine, ectopic and molar pregnancies. Floridon C; Nielsen O; Holund B; Sunde L; Westergaard JG; Thomsen SG; Teisner B Placenta; 1999 Nov; 20(8):711-21. PubMed ID: 10527826 [TBL] [Abstract][Full Text] [Related]
32. Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells. Gupta R; Chetty C; Bhoopathi P; Lakka S; Mohanam S; Rao JS; Dinh DE Int J Oncol; 2011 Mar; 38(3):733-44. PubMed ID: 21181094 [TBL] [Abstract][Full Text] [Related]
33. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder. Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521 [TBL] [Abstract][Full Text] [Related]
34. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645 [TBL] [Abstract][Full Text] [Related]
35. Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer. Miller-Kleinhenz J; Guo X; Qian W; Zhou H; Bozeman EN; Zhu L; Ji X; Wang YA; Styblo T; O'Regan R; Mao H; Yang L Biomaterials; 2018 Jan; 152():47-62. PubMed ID: 29107218 [TBL] [Abstract][Full Text] [Related]
38. Co-expression of uPAR and CXCR4 promotes tumor growth and metastasis in small cell lung cancer. Li Y; Shen Y; Miao Y; Luan Y; Sun B; Qiu X Int J Clin Exp Pathol; 2014; 7(7):3771-80. PubMed ID: 25120753 [TBL] [Abstract][Full Text] [Related]
39. Specific expression of OATPs in primary small cell lung cancer (SCLC) cells as novel biomarkers for diagnosis and therapy. Brenner S; Klameth L; Riha J; Schölm M; Hamilton G; Bajna E; Ausch C; Reiner A; Jäger W; Thalhammer T; Buxhofer-Ausch V Cancer Lett; 2015 Jan; 356(2 Pt B):517-24. PubMed ID: 25301452 [TBL] [Abstract][Full Text] [Related]
40. Characterization of sphere-forming cells with stem-like properties from the small cell lung cancer cell line H446. Qiu X; Wang Z; Li Y; Miao Y; Ren Y; Luan Y Cancer Lett; 2012 Oct; 323(2):161-70. PubMed ID: 22521544 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]